{"id":"https://openalex.org/W2378355083","doi":null,"title":"The first antisense drug-fomivirsen","display_name":"The first antisense drug-fomivirsen","alternate_titles":[],"publication_year":2002,"publication_date":"2002-01-01","ids":{"openalex":"https://openalex.org/W2378355083","mag":"2378355083"},"language":"en","primary_location":{"id":"mag:2378355083","doi":null,"is_oa":false,"landing_page_url":"https://oversea.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&filename=XYYL200205015","pdf_url":null,"source":{"id":"https://openalex.org/S2764853906","display_name":"Chinese Journal of New Drugs and Clinical Remedies","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4323986928","host_organization_name":"Zhongguo Yao Xuehui Shanghai Fenhui","host_organization_lineage":["https://openalex.org/P4323986928"],"host_organization_lineage_names":["Zhongguo Yao Xuehui Shanghai Fenhui"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Chinese Journal of New Drugs and Clinical Remedies","raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W2378355083"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051767745","display_name":"Ding\u2010Feng Su","orcid":"https://orcid.org/0000-0003-0160-3789","observed_orcids":["https://orcid.org/0000-0003-0160-3789"]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Su Ding-Feng","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5051767745"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10981","display_name":"Cytomegalovirus and herpesvirus research","score":0.8270999789237976,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10981","display_name":"Cytomegalovirus and herpesvirus research","score":0.8270999789237976,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10625","display_name":"Herpesvirus Infections and Treatments","score":0.03359999880194664,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.02239999920129776,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fomivirsen","display_name":"fomivirsen","score":1.0},{"id":"https://openalex.org/keywords/antisense-therapeutics","display_name":"antisense therapeutics","score":0.7179999947547913},{"id":"https://openalex.org/keywords/cytomegalovirus-retinitis","display_name":"cytomegalovirus retinitis","score":0.9929999709129333},{"id":"https://openalex.org/keywords/aids","display_name":"AIDS","score":0.890999972820282},{"id":"https://openalex.org/keywords/antiviral-mechanism","display_name":"antiviral mechanism","score":0.8700000047683716},{"id":"https://openalex.org/keywords/viral-replication-inhibition","display_name":"viral replication inhibition","score":0.7440000176429749},{"id":"https://openalex.org/keywords/clinical-trials","display_name":"clinical trials","score":0.5210000276565552}],"concepts":[{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.7048813700675964},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6424088478088379},{"id":"https://openalex.org/C2908938912","wikidata":"https://www.wikidata.org/wiki/Q4067124","display_name":"Antisense therapy","level":5,"score":0.5556172728538513},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5513413548469543},{"id":"https://openalex.org/C2777016524","wikidata":"https://www.wikidata.org/wiki/Q630552","display_name":"Retinitis","level":4,"score":0.5486215353012085},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4377521574497223},{"id":"https://openalex.org/C2779756493","wikidata":"https://www.wikidata.org/wiki/Q846227","display_name":"Antiviral drug","level":3,"score":0.434173583984375},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.42979487776756287},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.33102643489837646},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.19243764877319336},{"id":"https://openalex.org/C2779820661","wikidata":"https://www.wikidata.org/wiki/Q6929","display_name":"Human cytomegalovirus","level":3,"score":0.19043055176734924},{"id":"https://openalex.org/C67705224","wikidata":"https://www.wikidata.org/wiki/Q11053","display_name":"RNA","level":3,"score":0.17118659615516663},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10971498489379883},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.08705154061317444},{"id":"https://openalex.org/C14363569","wikidata":"https://www.wikidata.org/wiki/Q418639","display_name":"Locked nucleic acid","level":4,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2378355083","doi":null,"is_oa":false,"landing_page_url":"https://oversea.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&filename=XYYL200205015","pdf_url":null,"source":{"id":"https://openalex.org/S2764853906","display_name":"Chinese Journal of New Drugs and Clinical Remedies","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4323986928","host_organization_name":"Zhongguo Yao Xuehui Shanghai Fenhui","host_organization_lineage":["https://openalex.org/P4323986928"],"host_organization_lineage_names":["Zhongguo Yao Xuehui Shanghai Fenhui"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Chinese Journal of New Drugs and Clinical Remedies","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4233200009","https://openalex.org/W2079266971","https://openalex.org/W1575330800","https://openalex.org/W4224283538","https://openalex.org/W2034893102","https://openalex.org/W4241213001","https://openalex.org/W2043087580","https://openalex.org/W4243131187","https://openalex.org/W2490340557","https://openalex.org/W4237375085"],"abstract_inverted_index":{"Fomivirsen":[0],"is":[1,10,35],"the":[2,19,82],"first":[3],"antisense":[4,39],"drug":[5],"approved":[6],"by":[7],"FDA.":[8],"It":[9],"composed":[11],"of":[12,22,33,41,53,87],"21":[13],"phosphorothioate":[14],"nucleotides,":[15],"and":[16,50,74,84],"used":[17],"for":[18],"local":[20],"treatment":[21],"cytomegalvirus":[23],"(CMV)":[24],"retinitis":[25],"in":[26],"patients":[27],"with":[28],"AIDS.":[29],"The":[30,78],"antiviral":[31],"mechanism":[32],"fomivirsen":[34],"mainly":[36],"due":[37],"to":[38],"inhibition":[40,52],"human":[42,54],"CMV":[43,55],"mRNA,":[44],"which":[45],"makes":[46],"it":[47],"produce":[48],"specific":[49],"potent":[51],"replication.":[56],"This":[57],"new":[58],"agent":[59],"has":[60],"several":[61],"advantages,":[62],"including":[63],"long-lasting":[64],"curative":[65],"effects":[66],"(1":[67],"wk":[68],"at":[69],"least),":[70],"less":[71],"administration":[72],"frequency,":[73],"few":[75],"adverse":[76],"reactions.":[77],"review":[79],"focuses":[80],"on":[81],"pharmacology":[83],"clinical":[85],"study":[86],"fomivirsen.":[88]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2378355083","counts_by_year":[],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
